BCAX - Bicara Therapeutics Inc. Common Stock
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$28.60
DETAILS
HIGH:
$42.00
LOW:
$18.00
MEDIAN:
$28.00
CONSENSUS:
$28.60
UPSIDE:
31.92%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 14.58 |
| Quick Ratio | 14.58 |
| Solvency Ratio | -4.666 |
| Cash Ratio | 3.34 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-6.67
Peers avg: 19.7
|
| PEG Ratio | -0.07 |
| Forward PEG | -0.07 |
| Price/Book | 2.29 |
| Price/Sales | 0.00 |
| Price/FCF | -8.59 |
| Price/Op Cash Flow | -8.61 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0040 |
| Debt/Equity | 0.0043 |
| Debt/Capital | 0.0042 |
| Long-Term Debt/Capital | 0.0015 |
| Financial Leverage | 1.07 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -3.690 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.3% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -139.50 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -95.64 |
| Operating Cash Flow Coverage | -62.48 |
| Capital Expenditure Coverage | -381.55 |
| Dividend + Capital Expenditure Coverage | -381.55 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -2.523 |
| Debt/Share | 0.0313 |
| Cash/Share | 7.59 |
| Book Value/Share | 7.34 |
| Tangible BV/Share | 7.34 |
| Equity/Share | 7.34 |
| Operating Cash Flow/Share | -1.954 |
| Capital Expenditure/Share | 0.005 |
| FCF/Share | -1.959 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.002 |
| Earnings Before Tax/EBIT | 0.885 |
| Price/Fair Value | 2.29 |
| Debt/Market Cap | 0.0019 |
| Effective Tax Rate | -0.2% |
| Enterprise Value Multiple | -5.30 |